Approved Hospital Formulary
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

ondansetron

ondansetron
Brand names: Zofran
Form Strength
SOLUTION, INJECTABLE 2 mg/mL
SOLUTION, INTRAVENOUS 32 mg/50 mL-D5%
SOLUTION, ORAL 4 mg/5 mL
TABLET, DISINTEGRATING, ORAL 4 mg; 8 mg
TABLET, ORAL 4 mg


Additional Information:
Top 100 Hospital Administered Drug
Drug Name Common Side Effects
ondansetron
  • headache
  • tiredness or weakness
  • constipation

Adult Patients: IV ondansetron single dose NOT to exceed 16 mg. See FDA Drug Safety Communication

Pediatric patients: IV ondansetron dosing NOT to exceed 0.25 mg/kg/dose (maximum: 16 mg) with a daily maximum of 0.5 mg/kg. See Drug Monograph.

May be given via hypodermoclysis (HDC/subcutaneous infusion). See Procedure 904.4991


Last updated: Dec. 9, 2020







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.